April 13, 2026 – Thermo Fisher Scientific introduced a strategic information collaboration with HealthVerity, a number one real-world information (RWD) market, to boost data-driven scientific growth and proof era for biopharmaceutical sponsors.

By the settlement, Thermo turns into Fisher’s PPD^™ scientific analysis corporations achieve enterprise-level entry to HealthVerity’s TaXOnomy^® claims dataset, representing greater than 270 million anonymized affected person lives within the U.S. healthcare system.

The datasets will present deep insights into illness prevalence, remedy patterns and supplier exercise, additional strengthening the scientific analysis neighborhood’s information and AI-driven providers in trial feasibility and optimization, recruitment and real-world proof era. The settlement additionally gives entry to a market of greater than 70 curated information sources, together with digital well being data, laboratory outcomes and different specialised information units. With streamlined entry to longitudinal claims and linked information units, the corporate can ship extra correct website choice methods and improved ramp-up timelines.

Proceed studying